| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/19/2009 | US20090047224 Cosmetic Process for Preventing or Treating the Signs of Skin Ageing or the Orange-Peel Appearance |
| 02/19/2009 | US20090047221 Compounds and compositions useful in the treatment of neoplasia |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2024363A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives |
| 02/18/2009 | EP2024361A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof |
| 02/18/2009 | EP2024353A2 Pyrazole compounds |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP2024331A1 Crystalline form of atorvastatin calcium stable after storage |
| 02/18/2009 | EP1928833B1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 02/18/2009 | EP1723143B1 Amino cyclopropane carboxamide derivatives as bradykinin antagonists |
| 02/18/2009 | EP1603886B1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370875A Optical recording medium and azo metal chelate compound |
| 02/18/2009 | CN101370804A Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 02/18/2009 | CN101370802A Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 02/18/2009 | CN101370791A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370788A Morpholino pyrimidine derivatives and their use in therapy |
| 02/18/2009 | CN101370786A Substituted imidazoles and their use as pesticides |
| 02/18/2009 | CN101370772A Diketooxime ester compound and use thereof |
| 02/18/2009 | CN101369633A Pyran derivative |
| 02/18/2009 | CN101367856A Methods and compositions for treating hepatitis c virus |
| 02/18/2009 | CN101367796A Process for preparing triglycidyl isocyanurate |
| 02/18/2009 | CN101366714A Acetylene derivatives having mGluR5 antagonistic activity |
| 02/18/2009 | CN100462363C Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/17/2009 | US7491831 PPAR active compounds |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491743 Inhibitors of cellular necrosis |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491738 Pest control agents |
| 02/17/2009 | US7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2317691C Triazole derivatives having antifungal activity |
| 02/17/2009 | CA2257010C Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 02/17/2009 | CA2221473C Hydroxyphenyltriazines |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009019561A2 Process for preparing chiral compounds |
| 02/12/2009 | WO2009019553A2 Imidazopyridinones |
| 02/12/2009 | WO2009019304A1 A process for the preparation of olmesartan medoxomil |
| 02/12/2009 | WO2009019303A2 A process for the preparation or purification of olmesartan medoxomil |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2008107480A8 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators |
| 02/12/2009 | WO2008051420A3 Dichroic-photochromic compounds and devices |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090042962 Therapeutic Agent for Keratoconjunctival Disorder |
| 02/12/2009 | US20090042961 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 02/12/2009 | US20090042916 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto |
| 02/12/2009 | US20090042907 Bicyclic aromatic sulfinyl derivatives |
| 02/12/2009 | US20090042888 Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 02/12/2009 | US20090042886 Benzamide Inhibitors of the P2X7 Receptor |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042837 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/12/2009 | US20090041721 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/12/2009 | CA2707365A1 A process for the preparation of olmesartan medoxomil |
| 02/12/2009 | CA2707334A1 A process for the preparation or purification of olmesartan medoxomil |
| 02/12/2009 | CA2707030A1 Imidazopyridinones |
| 02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |
| 02/12/2009 | CA2695357A1 Process for preparing chiral compounds |
| 02/12/2009 | CA2693495A1 Viral polymerase inhibitors |
| 02/11/2009 | EP2022790A1 A process for the preparation or purification of olmesartan medoxomil |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2021381A2 Hafnium complexes of heterocyclic organic ligands |
| 02/11/2009 | EP2021333A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 02/11/2009 | EP2021327A2 Antidiabetic bicyclic compounds |
| 02/11/2009 | EP2021324A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 02/11/2009 | EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/11/2009 | CN101365686A Heterocyclic derivatives as modulators of ion channels |
| 02/11/2009 | CN101365682A Bicyclic compounds with kinase inhibitory activity |
| 02/11/2009 | CN101365680A 3,5-substituted piperidine compounds as renin inhibitors |
| 02/11/2009 | CN101365678A Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 02/11/2009 | CN101365676A Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN100460395C Aromatic-cyclo and heterocyclo acylmethyl imidazole salts compound and method for preparing same |
| 02/10/2009 | US7488824 Process for the production of substituted nicotinic acid esters |
| 02/10/2009 | US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory |
| 02/10/2009 | US7488820 Naphthofluorescein-based metal sensors, and methods of making and using the same |
| 02/10/2009 | US7488751 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 02/10/2009 | US7488750 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 02/10/2009 | US7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 02/10/2009 | US7488742 Therapy for thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/10/2009 | US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors |
| 02/10/2009 | US7488727 Thiazole compounds useful as inhibitors of protein kinase |
| 02/10/2009 | CA2186511C Pyrimidinyl derivatives as interleukin inhibitors |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2009016565A1 Tricyclic compounds for the treatment of inflammatory disorders |
| 02/05/2009 | WO2009016560A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 02/05/2009 | WO2009016498A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 02/05/2009 | WO2009016253A2 Cyanomethyl substituted n-acyl tryptamines |
| 02/05/2009 | WO2009016222A1 Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives |
| 02/05/2009 | WO2009016219A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives |